Ledger.Open graph →
SEC Form D · filed April 14, 2021

Ventus Therapeutics U.S., Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Daniel Koerwer · Walthum, MAExecBrendan Bulik-Sullivan · Walthum, MADirectorJerel Davis · Walthum, MADirectorMichael Crackower · Waltham, MAExecZachary Mcnealy · Walthum, MAExecJosh Resnick · Walthum, MADirectorMarcelo Bigal · Walthum, MAExec · DirectorSteven James · Walthum, MADirectorMatej Moravcik · Selce, 2BExecRudolf Kadlec · Zvole u Prahy, 2NDirectorJamie Price · New York, NYExecValerie Brown · New York, NYDirectorMilton R. Berlinski · New York, NYExecJon Frojen · New York, NYExec · DirectorAndrej Kiska · Luxembourg-Findel, LuxembourgDirectorMartin Schmid · Stare Hradiste, 2NDirectorGunnar K. Gunnarsson · Wayne, PAExecJack K. Eadie · Wayne, PADirectorVladimir K. Tamarkin · Wayne, PADirectorCharlie K. Wuischpard · Wayne, PADirectorMatthew Snyder · ARMONK, NYDirectorNicholas C. Stacey · Denver, COExecIvana Faltysova · Grand Cayman, Cayman IslandsExecKevin Phillip · Grand Cayman, Cayman IslandsExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗